How do you choose the appropriate first line treatment between everolimus, somatostatin analogues, or cytotoxic chemotherapy in patients with good ECOG PS and widely metastatic atypical carcinoid of the lung?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Texas Health Science Center at Houston
Answered on
If the patient is not symptomatic from tumor burden, can start with somatostatin analogues and then add everolimus on progression. Cytotoxic chemotherapy for patients who have progressed on everolimus.
Join for free or sign in to see the full answer